fashion -WSS

fashion

author：hotspot 2025-09-02 05:49:32 - browse：978

Adam's take main illustration — Molly Ferguson/STAT

This week, I address pushback I received on my Novartis-MorphoSys column. But first, a preview of the expected readout from Gritstone Bio’s neoantigen cancer vaccine study.

A looming test for neoantigen cancer vaccines

Before the end of the quarter, Gritstone Bio will release preliminary results from a randomized, Phase 2 clinical trial investigating a personalized therapeutic cancer vaccine in microsatellite-stable colon cancer, a type of “immunologically cold” tumor that is resistant to immunotherapies like PD-1/PD-L1 inhibitors.

The Gritstone vaccine is designed to train a patient’s own T cells to recognize and kill cancer cells by targeting mutated cancer proteins, called neoantigens, that are unique to a patient’s own tumor. It’s a relatively new approach for cancer vaccines — made possible by powerful and relatively inexpensive genomic sequencing of tumors – that is intended to overcome all the previous failures in the field. Gritstone’s effort is also similar to one being used by Moderna and Merck that has reported encouraging results in melanoma — and is now being investigated in a Phase 3 study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Maisha Meds is a PBM, but don't call it that

explore

WSS

Dana Farber says 6 studies to be retracted and 31 corrected

To bolster infectious disease surveillance, genomics powerhouses team up

Biogen walks away from Aduhelm, years after polarizing approval

Syphilis numbers in the United States reach record heights

Maisha Meds is a PBM, but don't call it that

Zyn nicotine pouches become unlikely player in latest culture war

explore

fashion

A looming test for neoantigen cancer vaccines

hotspot

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Zyn nicotine pouches become unlikely player in latest culture war

Medical leaders decry Supreme Court decision on affirmative action

Wegovy leads to weight loss. Can it treat depression, too?

As demand for Covid shots wanes, Moderna seeks its next success

CVS is on a mission to consolidate health care. Will it work?

George Santos makes 1st court appearance after pleading not guilty to 13 counts

A pediatrician calls for Congress to pass the child tax credit deal

Drug repurposing or repositioning? The language matters

Zyn nicotine pouches become unlikely player in latest culture war

focus

The Affordable Care Act has saved billions in health care costs

Why you shouldn’t ask, “What country has the best health care?”

Inaction leaves children at risk from dangerous chemotherapy drug

High breast density mammograms need follow

Printout prescription drug information shouldn’t go digital

A pediatrician calls for Congress to pass the child tax credit deal

Wikipedia

explore

entertainment

leisure time